Croissance Clinical Research,Hyderabad, India, 2015 is proud to announce that it has signed an agreement with Indian Immunological to provide the data management services.
IIL is the market leader in veterinary biological’s in India and operates one of the largest plants in the world for veterinary vaccines. IIL is also the third largest animal health player in India with the largest selling brand – Raksha FMD Vaccine. With depth in marketing throughout the country and reaching out to the smallest of the livestock keepers, many products of IIL occupy top slots in the market.
IIL started manufacturing human vaccines in 1998 at the specific request of the Government of India. IIL is the second company in the world and first in India to launch the purified Vero cell rabies vaccine (PVRV) with the brand – Abhayrab. This led to the discontinuation of use of the older and unsafe sheep brain vaccine (also termed nerve tissue vaccine – NTV) in the Country.
IIL is a major player in the human vaccine market in India, focusing on the pediatric and rabies vaccine segments. HBI’s unique marketing concepts such as Abhay Clinics (one stop vaccination centres) and Abhay Shoppe (vaccine on call service) have helped create a strong retail presence. IIL is also a major supplier of pediatric vaccines to India’s large Universal Immunization Programme.